3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
15
INDUSTRY
5
OTHER_GOV
2
NIH
1
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Conditions
Carcinoma, Non-Small-Cell Lung
5
Melanoma
3
Uveal Melanoma
2
Neoplasms
2
Lymphoma, B-Cell
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcopenia
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Lymphoma, Follicular
1
Gastrointestinal Stromal Tumors
1
Esophageal Squamous Cell Carcinoma
1
Efficacy, Team
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Chondrosarcoma
1
Carcinoma, Renal Cell
1
Bone Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Melphalan
3
Interleukin-2
3
Nivolumab
2
Ipilimumab
2
pembrolizumab
1
entinostat
1
Tramadol
1
Ibuprofen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Uveal Melanoma
×
Nivolumab
×
Clear all
NCT04463368
2025-03-28
SCANDIUM II
Vastra Gotaland Region
Phase 1
Completed
18 enrolled
NCT06519266
2024-11-25
SCANDIUM-III
Vastra Gotaland Region
Phase 3
Recruiting
40 enrolled